Biosafety
Sponsored Programs & Compliance Update
We are excited to share that beginning January 2, 2026, the Office of Sponsored Programs and the Office of Integrity and Compliance will be shared among the 吃瓜官网 System.
We will provide more updates here as they become available. In the meantime, continue to work with Abby Gade in Research and Sponsored Programs.
Effective January 20, 2026, the Institutional Review Boards of 吃瓜官网 and Colorado State University Fort Collins have combined under a single Federalwide Assurance (FWA) registration with the Office of Human Research Protection (OHRP). This change is in response to a system policy change for research compliance published on January 01, 2026. .
All new submissions to the IRB office will be reviewed by either a designated reviewer within the office or a combined committee including representatives from both Fort Collins and Pueblo campuses.
For more information about research within the 吃瓜官网 System, visit or email csu_irb@colostate.edu .
Human Research Protections Program Director
kathy.kioussopoulos@colostate.edu • (970) 491-3786
Biohazards include biological agents and toxins infectious to humans, animals, wildlife, plants such as parasites, viruses, bacteria, fungi, prions, and biologically-active materials such as toxins, allergens, and venoms. In addition to causing disease in living organisms, biohazards can cause significant damage to the environment.
Therefore, the mission of the 吃瓜官网 Biosafety Committee is to ensure that all activities involving biohazardous materials are conducted in compliance with federal, state, and local regulations and applicable University policies. The Biosafety Committee will determine "Biorisk management," the effective management of risks posed by working with infectious agents and toxins in laboratories, and the range of practices and procedures to ensure biosecurity and biosafety and biocontainment of those infectious agents and toxins.
At 吃瓜官网, it is required to attain the approval of all projects involving recombinant DNA, synthetic nucleic acids, viral pathogens, bacterial pathogens, prions, biological toxins, human blood and tissues, non-human primate blood and tissues, clinical gene transfers, or clinical xenotransplantations.
